Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Coronavirus
Inhibitors of Virion Maturation and Assembly
Inhibitors of Bacterial DNA Synthesis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 15, 2026

Procedures for the Identification of SARS-CoV-2 Entry Inhibitors as Potential Antivirals using MLV-Based Pseudoviruses
Published on: February 27, 2026
1Arclin USA LLC, 1150 Sanctuary Parkway, Suite 100, Alpharetta, Georgia 30009, United States.
Novel compounds are presented for inhibiting viral replication and treating coronavirus infections. These pharmaceutical compositions and preparation processes offer new therapeutic strategies against coronaviruses.
Area of Science:
Background: